Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on July 15, 2026

Jul. 15, 2026

InnoCare Announces Phase III Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Atomic Dermatitis

Indeterminate GlobeNewswire

Jul. 15, 2026

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

Indeterminate GlobeNewswire

Jul. 15, 2026

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

Indeterminate GlobeNewswire

Jul. 15, 2026

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™

Indeterminate GlobeNewswire

Jul. 15, 2026

Repligen to Report Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 15, 2026

Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™…

Indeterminate GlobeNewswire

Jul. 15, 2026

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

BioCryst Appoints David W. Jenkins as Chief Scientific Officer

Indeterminate GlobeNewswire

Jul. 15, 2026

INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study

Indeterminate GlobeNewswire

Jul. 15, 2026

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

Indeterminate GlobeNewswire

Jul. 15, 2026

Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

BPGbio Reports Encouraging Preliminary Data from Ongoing Phase 2 Study of BPM31510 in Newly Diagnosed Glioblastoma

Indeterminate GlobeNewswire

Jul. 15, 2026

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation

Indeterminate GlobeNewswire

Jul. 15, 2026

Nxera Pharma Webinar for Financial Results Presentation - 2Q2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Epoch Biotech Highlights New Preclinical Data for APOE Christchurch-Mimetic Antibody at AAIC 2026 Demonstrating Favorable PK/PD and Differentiated Biomarker Approach

Indeterminate GlobeNewswire

Jul. 15, 2026

WONDERLAB Spotlights Gut Health and Innate Immunity, Featuring Its Proprietary Strain GOLDGUT-M520

Indeterminate GlobeNewswire

Jul. 15, 2026

Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S.

Indeterminate GlobeNewswire